IBN
Închide

Lista articolelor în limba engleza

Print PDF
Afisarea articolelor: 1-1(1)
2018
1.

A CCR2/5 inhibitor, PF-04634817, is inferior to monthly ranibizumab in the treatment of diabetic macular edema

. Investigative Ophthalmology and Visual Science. 2018, nr. 6(59), 2669-2659. ISSN 0146-0404. (Cat. )
 
 

1-1 of 1